Austria vs Finland: The number of people with susceptibility test result for rifampicin
Austria
86.84
in 2021
Finland
86.14
in 2021
Austria rank
80th
Finland rank
83rd
The number of people with susceptibility test result for rifampicin over time
- Austria
- Finland
How they compare
Austria currently reports 86.84 against 86.14 in Finland, a difference of 0.7.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Finland ahead.
Austria ranks 80th and Finland ranks 83rd of 146 countries.
Finland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Austria | Finland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.78 | 93.15 | 4.36 | Finland |
| 2020s | 86.89 | 91.15 | 4.26 | Finland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Finland?
- Austria, at 86.84 against 86.14 in Finland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Finland?
- 0.7, with Austria ahead.
- How many years of comparable data are there for Austria and Finland?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Finland rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 80th and Finland ranks 83rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.